JP2006077019A5 - - Google Patents

Download PDF

Info

Publication number
JP2006077019A5
JP2006077019A5 JP2005272533A JP2005272533A JP2006077019A5 JP 2006077019 A5 JP2006077019 A5 JP 2006077019A5 JP 2005272533 A JP2005272533 A JP 2005272533A JP 2005272533 A JP2005272533 A JP 2005272533A JP 2006077019 A5 JP2006077019 A5 JP 2006077019A5
Authority
JP
Japan
Prior art keywords
group
alkyl group
substituted
alkyl
halogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2005272533A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006077019A (ja
Filing date
Publication date
Priority claimed from GBGB9920872.0A external-priority patent/GB9920872D0/en
Application filed filed Critical
Publication of JP2006077019A publication Critical patent/JP2006077019A/ja
Publication of JP2006077019A5 publication Critical patent/JP2006077019A5/ja
Withdrawn legal-status Critical Current

Links

JP2005272533A 1999-09-04 2005-09-20 逆転写酵素のインヒビターとしてのベンゾフェノン類 Withdrawn JP2006077019A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9920872.0A GB9920872D0 (en) 1999-09-04 1999-09-04 Benzophenones as inhibitors of reverse transcriptase

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001521729A Division JP3739704B2 (ja) 1999-09-04 2000-08-31 逆転写酵素のインヒビターとしてのベンゾフェノン類

Publications (2)

Publication Number Publication Date
JP2006077019A JP2006077019A (ja) 2006-03-23
JP2006077019A5 true JP2006077019A5 (hr) 2007-11-08

Family

ID=10860319

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001521729A Expired - Fee Related JP3739704B2 (ja) 1999-09-04 2000-08-31 逆転写酵素のインヒビターとしてのベンゾフェノン類
JP2005272533A Withdrawn JP2006077019A (ja) 1999-09-04 2005-09-20 逆転写酵素のインヒビターとしてのベンゾフェノン類

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2001521729A Expired - Fee Related JP3739704B2 (ja) 1999-09-04 2000-08-31 逆転写酵素のインヒビターとしてのベンゾフェノン類

Country Status (26)

Country Link
US (1) US7273863B1 (hr)
EP (2) EP1710238A1 (hr)
JP (2) JP3739704B2 (hr)
KR (2) KR20020086850A (hr)
CN (4) CN1213038C (hr)
AR (1) AR033344A1 (hr)
AT (1) ATE325106T1 (hr)
AU (1) AU770302C (hr)
BR (1) BR0013771A (hr)
CA (1) CA2383782A1 (hr)
CZ (1) CZ2002807A3 (hr)
DE (1) DE60027729T2 (hr)
ES (1) ES2261242T3 (hr)
GB (1) GB9920872D0 (hr)
HU (1) HUP0202593A3 (hr)
IL (1) IL148322A0 (hr)
MX (1) MXPA02002347A (hr)
MY (1) MY142948A (hr)
NO (1) NO323156B1 (hr)
NZ (1) NZ517451A (hr)
PE (1) PE20010539A1 (hr)
PL (1) PL354760A1 (hr)
TR (1) TR200201187T2 (hr)
TW (1) TWI286550B (hr)
WO (1) WO2001017982A1 (hr)
ZA (1) ZA200201664B (hr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6589801A (en) * 2000-04-28 2001-11-12 F. Hoffmann-La Roche Ag P-(sulfonyl)aryl and heteroaryls
TWI332956B (en) * 2002-04-26 2010-11-11 Gilead Sciences Inc Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
JP2006521402A (ja) * 2003-03-27 2006-09-21 スミスクライン ビーチャム コーポレーション 逆転写酵素阻害剤を調製するための方法
WO2005002626A2 (en) 2003-04-25 2005-01-13 Gilead Sciences, Inc. Therapeutic phosphonate compounds
US7470724B2 (en) 2003-04-25 2008-12-30 Gilead Sciences, Inc. Phosphonate compounds having immuno-modulatory activity
US7300924B2 (en) 2003-04-25 2007-11-27 Gilead Sciences, Inc. Anti-infective phosphonate analogs
US7432261B2 (en) 2003-04-25 2008-10-07 Gilead Sciences, Inc. Anti-inflammatory phosphonate compounds
US7407965B2 (en) 2003-04-25 2008-08-05 Gilead Sciences, Inc. Phosphonate analogs for treating metabolic diseases
ATE490788T1 (de) 2003-04-25 2010-12-15 Gilead Sciences Inc Antivirale phosphonate analoge
US7427636B2 (en) 2003-04-25 2008-09-23 Gilead Sciences, Inc. Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
MXPA05011296A (es) 2003-04-25 2006-01-24 Gilead Sciences Inc Conjugados de fosfonato inhibidores de la cinasa.
US7452901B2 (en) 2003-04-25 2008-11-18 Gilead Sciences, Inc. Anti-cancer phosphonate analogs
WO2005044308A1 (en) 2003-10-24 2005-05-19 Gilead Sciences, Inc. Phosphonate analogs of antimetabolites
JP2007508843A (ja) 2003-10-24 2007-04-12 ギリアード サイエンシーズ, インコーポレイテッド 治療用化合物の同定のための方法および組成物
WO2005044279A1 (en) 2003-10-24 2005-05-19 Gilead Sciences, Inc. Purine nucleoside phosphonate conjugates
US20080287471A1 (en) 2003-12-22 2008-11-20 Maria Fardis 4'-Substituted Carbovir And Abacavir-Derivatives As Well As Related Compounds With Hiv And Hcv Antiviral Activity
ES2338060T3 (es) 2003-12-22 2010-05-03 Basilea Pharmaceutica Ag Componentes de tipo ariloxi y ariltoxia-cetofenona para el tratamiento del cancer.
FR2866880A1 (fr) * 2004-02-27 2005-09-02 Oreal Para-phenylenediamine secondaire n-alkylaminee ortho-et/ou meta-substituee, composition de teinture des fibres keratiniques contenant une telle para-phenylenediamine, procedes mettant en oeuvre cette composition et utilisations
CA2563180C (en) * 2004-04-23 2013-08-06 F. Hoffmann-La Roche Ag Non-nucleoside reverse transcriptase inhibitors
US7166738B2 (en) 2004-04-23 2007-01-23 Roche Palo Alto Llc Non-nucleoside reverse transcriptase inhibitors
US7625949B2 (en) 2004-04-23 2009-12-01 Roche Palo Alto Llc Methods for treating retroviral infections
WO2005121094A1 (en) * 2004-06-09 2005-12-22 Pfizer Limited Piperazine and piperidine derivatives as anti-hiv-agents
ES2720618T3 (es) 2004-07-27 2019-07-23 Gilead Sciences Inc Análogos de fosfonato de compuestos de inhibidores de VIH
US20060025480A1 (en) 2004-08-02 2006-02-02 Boehringer Ingelheim International Gmbh Benzoic acid derivatives as non nucleoside reverse transcriptase inhibitors
WO2006034583A1 (en) * 2004-09-30 2006-04-06 Boehringer Ingelheim International Gmbh & Co Kg Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors
EP1819348A1 (en) * 2004-12-01 2007-08-22 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and gw695634
AR057455A1 (es) 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
WO2007045573A1 (en) 2005-10-19 2007-04-26 F. Hoffmann-La Roche Ag Phenyl-acetamide nnrt inhibitors
CN101108178B (zh) * 2006-07-20 2010-09-15 复旦大学 一种亲环素a抑制剂在制备抗艾滋病药物中的应用
EP2226315A4 (en) 2007-12-28 2012-01-25 Carna Biosciences Inc 2-AMINOQUINAZOLINE DERIVATIVE
UA103329C2 (ru) 2008-07-08 2013-10-10 Гилиад Сайенсиз, Инк. Соли соединений-ингибиторов вич
WO2011060394A1 (en) * 2009-11-16 2011-05-19 Schering Corporation Compounds useful as chemokine receptor antagonists
CN102219717A (zh) * 2011-04-20 2011-10-19 复旦大学 N-苯基芳基甲酰胺衍生物及其制备方法和用途
CN102212022A (zh) * 2011-04-20 2011-10-12 复旦大学 二苯甲醇衍生物及其制备方法和用途
CN102229547A (zh) * 2011-04-20 2011-11-02 复旦大学 一种萘苯醚类苯磺酰胺衍生物及其制备方法和用途
CN102206177A (zh) * 2011-04-20 2011-10-05 复旦大学 1-萘基苯甲酮衍生物及其制备方法和用途
EP3116862B1 (en) * 2014-03-10 2019-04-17 Merck Sharp & Dohme Corp. Piperazine derivatives as hiv protease inhibitors
PL3661937T3 (pl) 2017-08-01 2021-12-20 Gilead Sciences, Inc. Formy krystaliczne ((s)-((((2r,5r)-5-(6-amino-9h-puryn-9-ylo)-4-fluoro-2,5-dihydrofuran-2-ylo)oksy)metylo)(fenoksy)fosforylo)-l-alaninianu etylu (gs-9131) do leczenia zakażeń wirusowych
RU2729792C1 (ru) * 2019-07-29 2020-08-12 Акционерное общество "Научно-производственное объединение "ДОМ ФАРМАЦИИ" Способы повышения растворимости лекарственного средства на основе пиримидинового производного бензофенона
CN113444010B (zh) * 2020-03-28 2023-09-05 南京正大天晴制药有限公司 一种沙芬酰胺有关物质的制备方法
CN113461502B (zh) * 2021-07-15 2023-07-28 台州臻挚生物科技有限公司 2-羟基二苯甲酮类化合物及其卤化衍生物的制备方法
CN114163361B (zh) * 2021-12-14 2023-08-01 无锡捷化医药科技有限公司 一种3-溴-5-羟基苯磺酰胺的制备方法
CN114292248A (zh) * 2022-01-18 2022-04-08 广东莱佛士制药技术有限公司 一种合成莱特莫韦中间体的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1552793A (hr) * 1966-12-07 1969-01-10
US4207234A (en) * 1975-07-07 1980-06-10 Fujisawa Pharmaceutical Co., Ltd. 4-Unsubstituted azetidinone derivatives and process for preparation thereof
JPS5973579A (ja) * 1982-10-19 1984-04-25 Kotobuki Seiyaku Kk ベンゾフラン又はベンゾチオフェン誘導体,この化合物を有効成分とする尿酸排泄剤及びその製造方法
JPS59181246A (ja) 1983-03-31 1984-10-15 Chugai Pharmaceut Co Ltd ベンゾフエノン誘導体
IN167395B (hr) 1987-07-21 1990-10-20 Hoffmann La Roche
WO1993015043A1 (en) 1992-01-24 1993-08-05 Yoshitomi Pharmaceutical Industries, Ltd. Arylalkananilide compound and pharmaceutical use thereof
FR2716195B1 (fr) 1994-02-14 1996-06-21 Sanofi Sa Dérivés de 3-acylamino-5-phényl-1,4-benzodiazépin-2-one polysubstitués, leur procédé de préparation et les compositions pharmaceutiques les contenant.
ES2138206T3 (es) 1994-05-31 2000-01-01 Teijin Ltd Derivados de naftaleno.
EP1082310A4 (en) * 1998-04-29 2001-09-12 Univ Georgetown METHODS RELATING TO THE IDENTIFICATION AND USE OF COMPOUNDS THAT BIND TO HLA MOLECULES AS AGONISTS OR ANTAGONISTS TO HLA

Similar Documents

Publication Publication Date Title
JP2006077019A5 (hr)
RU2012116505A (ru) Замещенные соединения амида
EP2592073B1 (en) Human protein tyrosine phosphatase inhibitors and their use
JP2004517080A5 (hr)
JP2004534035A5 (hr)
RU2009102516A (ru) Ингибиторы протеинтирозинфосфатазы человека и способы их использования
JP2017523972A5 (hr)
JP2004517087A5 (hr)
JP2010506825A5 (hr)
ZA200201664B (en) Benzophenones as inhibitors of reverse transcriptase.
JP2008516986A5 (hr)
JP2009529059A5 (hr)
JP2013530240A5 (hr)
JP2007523142A5 (hr)
JP2010508296A5 (hr)
RU2012132692A (ru) Новые ингибиторы s-нитрозоглутатионредуктазы
JP2006506340A5 (hr)
RU2008140940A (ru) Производное триазола или его соль
KR940005614A (ko) 디페닐 옥사졸 티아졸 및 이미다졸의 아데노신 재흡수 억제 유도체
RU2011153772A (ru) Фторированные аминотриазольные производные
JP2016523963A5 (hr)
JP2005526732A5 (hr)
JP2004521150A5 (hr)
JP2017214387A5 (hr)
RU2435763C2 (ru) Ингибиторы тирозинфосфатазы белка человека и способы применения